Other News

Creavo Medical Technologies Appoints Martin Frost as Chairman

Key appointment forms part of Creavo’s strategy to scale the Company Creavo’s Corsens® technology developed to improve patient care pathway in cardiac diagnostics COVENTRY, England–(BUSINESS WIRE)–Creavo Medical Technologies Ltd (Creavo), the medical device company developing innovative diagnostics techniques, has announced that it has appointed Martin Frost as Chairman of the […]

W. L. Gore & Associates Enhances GORE® VIABAHN® Endoprosthesis Portfolio With Lower Profile Delivery

Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization under fluoroscopy FLAGSTAFF, Ariz., Sept. 22, 2020 /PRNewswire/ — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced the U.S. launch of the lower profile, large […]

MedHub Receives CE Mark Approval for its AutoCathFFR Software

TEL AVIV, Israel, Sept. 22, 2020 /PRNewswire/ — MedHub, a med-tech company that is leveraging AI to help interventional cardiologists make better decisions, announced today that its AutoCathFFR system has been certified to bear the CE Mark, signifying compliance with the European Union’s health and environmental safety regulations. “Following our recent AMAR regulatory approval, the […]

Laurel Bridge Software and Ultromics Partnership Increases Accessibility to AI Solutions for Echocardiography

NEWARK, Del., Sept. 22, 2020 /PRNewswire/ — Laurel Bridge Software, a provider of software solutions that enable healthcare organizations to orchestrate their medical imaging workflows, announces a new partnership with Ultromics, a global health technology firm, which provides autonomous echocardiography analysis through innovative AI solutions. The Laurel Bridge AI Workflow Suite (AIWS) enables the Ultromics EchoGo suite of cloud-based AI […]

MicroVention-Terumo Announces New Leadership

The Company Appoints New President and CEO ALISO VIEJO, Calif., Sept. 22, 2020 /PRNewswire/ — MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the appointment of a new President and CEO, Mr. Carsten Schroeder. The MicroVention acting President and CEO, Kazuaki Kitabatake, who has been in his […]

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors, effective October 1, 2020. Ms. Giles will serve as a member of the Audit Committee of the Board and Dr. […]

PEDRA™ Technology, Inc. Secures $4.7M Series A Funding for Perfusion Monitoring Technology

Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia SINGAPORE, Sept. 22, 2020 /PRNewswire/ — PEDRA™ Technology, a Singapore-based developer of innovative deep-tissue perfusion monitors, today announced the completion of $4.7M Series A financing, with investors including SEEDS Capital, the investment arm of Enterprise Singapore,  M&L Healthcare Investments and […]

VivaLNK Supports Large Scale Atrial Fibrillation Study of Wearable ECG Sensors

Multi-year, 3,000 subjects study aims to detect biomarkers of early atrial transformation in atrial fibrillation CAMPBELL, Calif., Sept. 22, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare devices, announces that the University of California, San Francisco (UCSF) will be utilizing its continuous wearable ECG sensor for a 3,000 subject multi-year study on atrial […]

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease

Company pursuing additional application for JAN101 to treat COVID-19 complications Stable formulation and engineering for JAN101 will support Phase 2b PAD Study under the FDA’s Investigational New Drug (IND) #111703, expected to begin the first quarter of 2021 Scientific Advisory Board bolstered by expert additions LAS VEGAS, Sept. 22, 2020 /PRNewswire/ — JanOne […]